# Effect of Implantable Contraception on Type-2 DM and Metabolic Syndrome in Women With History of Gestational DM

> **NCT02114476** · NA · UNKNOWN · sponsor: **Mahidol University** · enrollment: 260 (estimated)

## Conditions studied

- Diabetes Mellitus
- Metabolic Syndrome

## Interventions

- **DEVICE:** progestin implant
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT02114476
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2017-03
- **Final completion:** 2022-06
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2018-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02114476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02114476, "Effect of Implantable Contraception on Type-2 DM and Metabolic Syndrome in Women With History of Gestational DM". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02114476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*